Protara Therapeutics (TARA)

• Market cap: $293M
• 1 day: -0.19%
• 5 days: 1.33%
• 1 month: 5.56%
• 3 months: -24.43%
• 6 months: 3.91%
• Year to date: -1.12%
• 1 year: 53.76%
• 5 years: -52.33%
• 10 years: -98.63%
• Sector: Healthcare
• Industry: Biotechnology

About: Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.

Employees: 51